tiprankstipranks
Trending News
More News >

LENSAR Stockholders Approve Merger with Alcon Research

Story Highlights
LENSAR Stockholders Approve Merger with Alcon Research

Don’t Miss TipRanks’ Half-Year Sale

LENSAR ( (LNSR) ) has issued an update.

On July 2, 2025, LENSAR, Inc. held a virtual special meeting where stockholders voted on proposals related to a merger agreement with Alcon Research, LLC. The merger proposal, along with a compensation proposal for executives related to the merger, was approved by the requisite vote. The adjournment proposal was deemed unnecessary as there was a quorum present and sufficient proxies to approve the merger proposal.

The most recent analyst rating on (LNSR) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on LENSAR stock, see the LNSR Stock Forecast page.

Spark’s Take on LNSR Stock

According to Spark, TipRanks’ AI Analyst, LNSR is a Neutral.

LENSAR’s overall stock score is primarily impacted by its weak financial performance, characterized by persistent losses and financial instability. Technical analysis provides a slightly more positive outlook, but valuation metrics remain unattractive due to negative earnings. The absence of earnings call insights and corporate events does not alter the score.

To see Spark’s full report on LNSR stock, click here.

More about LENSAR

LENSAR, Inc. is a company operating in the medical technology industry, primarily focusing on the development and commercialization of femtosecond laser systems for cataract surgery.

Average Trading Volume: 146,567

Technical Sentiment Signal: Buy

Current Market Cap: $152.3M

For detailed information about LNSR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1